1O'Shea. Persistence of rubella antibody 8-18 years after vaccination[J].Brit medi J,1984,288:1043.
2Plotkin S A.Rubella vaccine.In:Plotkin S A,Mortier E A,eds.Vaccines,2nd edition[J].London,W.B.Saunders.1994.
3Briss PA, Fehrs LJ, Parker RA, et al. Sustained transmission of mumps in a hIgGhly vaccinated population: assessment of primary vaccine failure and waning vaccine- induced imumunity [J] . Infect Dis, 1994,169: 77 - 82.
4CDC. Measles, Mumps, and Rubella- Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps:Recommendations of the Advisory Committee on Immunization Practices (ACIP) [J] .MMWR, 1998, 47(No. RR- 8
5Bottinger M. Immunity to rubella before and after vaccination against measles,mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months[J].Vaccine, 1995,13:1759 - 1762.
6Watson JC, Pearson JA, Markowitz LE, et al. Evaluation of measles revaccination among school - entry - aged children [J]. Pediatrics,1996,97:68- 113.
7Davidkin I, Valle M, Julkunen I. Persistence of anti - mumps virus antibodies after a two - dose MMR vaccination. A nine - year follow - up[J]. Vaccine, 1995,13:1617 - 1622.
8Hersh BS, Fine PEM, Kent WK, et al. Mumps outbreak in a hIgGhly vaccinated population[J]. Pediatr, 1991,119:93 - 187.
7Dumitrescu A L,Abd E1-Aleem S,Morales-Aza B,et a1.A modelOfperiodontitis in the rat;effect of lipopolysaccharide onboneresorption,osteoclast activity,and local peptidergic innervation [J].J ClinPeriodontol,2004,31(8):596.
